Bortecade (bortezomib) for Injection is indicated for the treatment of multiple myeloma patients who have received at least 1 prior therapy and have demonstrated disease progression on the last therapy. Bortecade (bortezomib) for Injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.